Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation

American Journal of Cardiology

Volumn 84, Issue 9, 1999, Pages 1029-1032

  Blanc, Jean Jacques ^a   Voinov, Cristina ^b   Maarek, Martine ^b  

^a BREST UNIVERSITY HOSPITAL   (France)

^b Med Department Laboratoires   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; PROPAFENONE;

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA;

ADMINISTRATION, ORAL; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPAFENONE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0032743599     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00493-2     Document Type: Article

References (28)

1. Prystowsky E.N., Benson D.W., Fuster V., Hart R.G., Kay G.N., Myerburg R.J., Naccarelli G.V., Wyqe D.G. Management of patients with atrial fibrillation AHA medical statement. Circulation. 93:1996;1262-1277.
2. Gilligan D.M., Ellenbogen K.A., Epstein A.E. The management of atrial fibrillation. Am J Med. 101:1996;413-421.
3. Azpitarte J., Alvarez M., Baun O., Garcia R., Moreno E., Martin F., Tercedor L., Fernandez R. Value of a single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized double-blind controlled study. Eur Heart J. 18:1997;1649-1654.
4. Andrivet P., Boubakri E., Dove P.J., Mach V., Vu Ngoc C. A clinical study of amiodarone as a single oral dose in patients with recent-onset atrial tachyarrhythmia. Eur Heart J. 15:1994;1396-1402.
5. Capucci A., Boriani G., Botto G.L., Lenzi T., Rubino I., Falcone C., Trisoline G., Della Casa S., Binetti N., Cavazza M. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol. 74:1994;503-505.
6. Donovan K.D., Power B.M., Hockings B.E.F., Dobb G.J., Lee K.Y. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol. 75:1995;693-697.
7. Hou Z.Y., Chen C.Y., Tu M.S., Lin S.L., Chiang H.T., Woosley R.L. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. Eur Heart J. 16:1995;521-528.
8. Zehender M., Hohnloser S., Mullet B., Meinertz T., Just H. Effets of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation results of a comparative study and a 2 years follow-up . J Am Coll Cardiol. 19:1992;1054-1059.
9. Bianconi L., Boccadamo R., Pappalardo A., Gentili C., Pistolese M. Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset. Am J Cardiol. 64:1989;335-338.
10. Levy S., Lauribe P., Dolla E., Kou W., Kadish A., Calkins H., Pagannelli F., Moyal C., Bremondy M., Schark A. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation. 86:1992;1415-1420.
11. Alt E., Ammer R., Schmitt C., Evans F., Lehmann G., Pasquantonio J., Schoming A. A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. Eur Heart J. 18:1997;1796-1804.
12. Escoubet B., Coumel P., Poirier J.M., Maison-Blanche P., Jaillon P., Leclercq J.F., Menasche P., Cheymol G., Piwnica A., Lagier G., et al. Suppression of arrhythmias within hours after a simple dose of amiodarone and relation to plasma and myocardial concentrations. Am J Cardiol. 55:1985;696-702.
13. Boriani G., Capucci A., Lenzi T., Sanguinetti M., Magnani B. Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. Chest. 102:1995;355-358.
14. Suttorp M.J., Kingma J.H., Jessurun E.R., Lie-A-Huen L., Van Hemel N.M., Lie K.I. The value of class Ic antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol. 16:1990;1722-1727.
15. Negrini M., Gibelli G., De Ponti C. A comparison of propafenone and amiodarone in reversion of recent-onset atrial fibrillation to sinus rhythm. Current Ther Res. 55:1994;1345-1354.
16. Larbuisson R., Venneman I., Stiels B. The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery. J Cardiothoracic Vasc Anesthesia. 10:1996;229-234.
17. Boriani G., Biffi M., Capucci A., Botto G.G., Broffoni T., Rubino I., Della Casa S., Sanguinetti M., Magnani B. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med. 126:1997;621-625.
18. Capucci A., Boriani G., Rubino I., Della Casa S., Sanguinetti M., Magnani B. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol. 43:1994;305-313.
19. Weiner P., Ganam R., Ganem R., Zidan F., Rabner M. Clinical course of recent-onset atrial fibrillation treated with oral propafenone. Chest. 105:1994;1013-1016.
20. Fresco C., Proclemer A., Pavan A., Buia G., Vicentini A., Pavan D., Morgera T. Intravenous propafenone in paroxysmal atrial fibrillation:a randomized, placebo-controlled, double-blind, multicenter clinical trial. Clin Cardiol. 19:1996;409-412.
21. Gosselink A.T.M., Crijns H.J.G.M., Van Gelder I.D., Hillige H., Wiesfeld A.C., Lie K.I. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA. 267:1992;3289-3293.
22. Rosenbaum M.B., Chiale P.A., Halpern M.S., Nau G., Przybylski J., Levi R.J., Lazzari J.O., Elizari M.V. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 38:1976;934-944.
23. Wijffels M.C.E.F., Kirchof C.J.H.J., Dorland R., Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 92:1995;1954-1968.
24. Crijns H.J., Van Gelder I.C., Lie K.I. Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. Am J Cardiol. 62:1988;1303-1306.
25. Feld G.K., Chen P.S., Nicod P., Fleck P., Meyer D. Possible atrial proarrhythmic effects of class Ic antiarrhythmic drugs. Am J Cardiol. 66:1990;378-383.
26. Murdock C.J., Kyles A.E., Yeung-Lai-Wah J.A., Qi A., Vorderbrugge S., Kerr C.R. Atrial flutter in patients treated for atrial fibrillation with propafenone. Am J Cardiol. 66:1990;775-777.
27. Robertson C.E., Miller H.C. Extreme tachycardia complicating the use of disopyramide in atrial flutter. Br Heart J. 44:1980;602-603.
28. Weiner H.L., Mc Carthy E.A., Pritchett E.L.C. Regular ventricular rhythm in patients with symptomatic paroxysmal atrial fibrillation. J Am Coll Cardiol. 17:1991;1283-1287.